Astera Labs (NASDAQ:ALAB) Posts Earnings Results, Beats Estimates By $0.11 EPS

Astera Labs (NASDAQ:ALAB) released its quarterly earnings results on Tuesday. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11, FiscalAI reports. The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period last year, the firm posted $0.44 EPS. Astera Labs updated its Q3 2026 guidance to 1.160-1.210 EPS.

Here are the key takeaways from Astera Labs’ conference call:

• Record Q2 revenue reached $392.4 million, up 27% sequentially and 104% year over year, with broad-based strength across AI fabric and signal-conditioning products. Non-GAAP operating margin expanded to 39.1% and diluted EPS rose to $0.80.
• Management expects Q3 revenue of $540 million to $560 million, representing approximately 40% sequential growth at the midpoint, driven by the Scorpio X-Series volume ramp, PCIe 6.0 Aries demand, and early Taurus 800G shipments. Scorpio is expected to become the company’s largest product family in Q3.
• Scorpio X-Series is entering high-volume production with the lead customer, while more than 10 customers are engaged across production, pre-production, or qualification programs. Management said the platform could eventually deliver more than $1,000 of content per accelerator, supported by higher-radix switching, software-enabled in-network compute, and HyperCast features.
• Astera highlighted several longer-term growth opportunities, including UALink, CXL memory connectivity, optical interconnects, and custom silicon. Initial optical deployments are targeted for 2027, CPO products for 2028 and beyond, and custom CXL and connectivity design wins are expected to begin shipping in 2027.
• Q3 non-GAAP gross margin is expected to decline to approximately 72% from 73.7% in Q2 as product mix broadens toward switching and module-related revenue. Management expects margins to trend toward a long-term target of roughly 70% despite continued operating leverage.

Astera Labs Price Performance

Astera Labs stock traded up $40.62 during mid-day trading on Tuesday, reaching $361.67. 10,002,005 shares of the company were exchanged, compared to its average volume of 4,428,536. The company has a fifty day simple moving average of $361.12 and a 200-day simple moving average of $232.51. Astera Labs has a 12 month low of $97.89 and a 12 month high of $499.48. The firm has a market cap of $61.99 billion, a PE ratio of 237.82, a PEG ratio of 3.72 and a beta of 3.84.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q2 earnings and revenue beat expectations. Astera Labs reported adjusted earnings of $0.80 per share, above the $0.69 consensus estimate and up from $0.44 a year earlier. Revenue reached a record $392.4 million, exceeding the $360.85 million estimate and increasing 104.5% year over year. Astera Labs Beats Q2 Earnings and Revenue Estimates
• Positive Sentiment: Q3 guidance was well above analyst forecasts. Management projected earnings of $1.16-$1.21 per share and revenue of $540 million-$560 million, compared with consensus estimates of $0.73 per share and $410.3 million in revenue. The outlook implies another sharp acceleration in growth. Astera Labs Reports Second Quarter 2026 Financial Results
• Positive Sentiment: New product ramp is expected to drive the acceleration. Astera Labs said Q3 growth will be supported by production ramp-up of its Scorpio X-Series 320-lane fabric switch, alongside diversified demand across AI fabrics and signal-conditioning products. Astera Labs Stock Shoots Higher After Q2 Earnings
• Neutral Sentiment: Investor expectations were already elevated. Recent coverage highlighted optimism surrounding Astera Labs’ Amazon partnership and AI infrastructure exposure, helping the stock advance ahead of earnings. Its high valuation and volatility mean additional upside may depend on continued results that exceed expectations. Astera Labs Benefits From Amazon Partnership
• Negative Sentiment: One analyst target remains below the current market level. A previously reported price-target increase to $275 suggests some valuation caution, although that target predates the latest earnings report and guidance. Astera Labs Price Target Raised to $275

Wall Street Analyst Weigh In

Several research firms have weighed in on ALAB. Rothschild & Co Redburn initiated coverage on Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Susquehanna boosted their target price on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. JPMorgan Chase & Co. raised their price target on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Finally, Bank of America lifted their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. Thirteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus target price of $289.00.

Insider Activity

In related news, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the transaction, the director directly owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 1,676,845 shares of company stock worth $444,928,806. 10.40% of the stock is owned by insiders.

Hedge Funds Weigh In On Astera Labs

Hedge funds have recently bought and sold shares of the company. Compound Planning Inc. lifted its holdings in shares of Astera Labs by 98.3% during the 4th quarter. Compound Planning Inc. now owns 2,766 shares of the company’s stock worth $460,000 after acquiring an additional 1,371 shares during the period. Corient Private Wealth LLC increased its stake in Astera Labs by 1,335.8% in the fourth quarter. Corient Private Wealth LLC now owns 88,660 shares of the company’s stock valued at $14,749,000 after acquiring an additional 82,485 shares during the last quarter. Alberta Investment Management Corp bought a new position in Astera Labs in the fourth quarter valued at approximately $4,641,000. Mercer Global Advisors Inc. ADV raised its position in Astera Labs by 17.8% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 6,943 shares of the company’s stock valued at $1,075,000 after purchasing an additional 1,051 shares in the last quarter. Finally, Vident Advisory LLC raised its position in Astera Labs by 25.8% during the fourth quarter. Vident Advisory LLC now owns 9,841 shares of the company’s stock valued at $1,637,000 after purchasing an additional 2,021 shares in the last quarter. 60.47% of the stock is owned by institutional investors.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.